Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DNA Therapeutics SA

http://www.dna-therapeutics.com/

Latest From DNA Therapeutics SA

Onxeo Seeks Partner For Its Expanding Oncology Pipeline

Onxeo, a biotech company developing drugs for orphan oncology indications, plans to secure financial backing from a pharma partner for its lead product Livatag based on impending Phase III results, CEO Judith Greciet told Scrip in an interview.

Companies ImmunoOncology

Deals In Depth: February 2016

Baxalta signed its first major CART deal, with Precision BioSciences; Stryker spent over $4bn to acquire Sage and Physio-Control. Coherus BioSciences and Kinetic Concepts/KCI USA completed big debt offerings.

BioPharmaceutical Medical Device
See All

Company Information

UsernamePublicRestriction

Register